Circulating resistin levels in essential hypertension

Clinical Endocrinology

Volumn 59, Issue 4, 2003, Pages 507-510

  Furuhashi, Masato ^a   Ura, Nobuyuki ^a   Higashiura, Katsuhiro ^a   Murakami, Hideyuki ^a   Shimamoto, Kazuaki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FATTY ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; RESISTIN; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ESSENTIAL HYPERTENSION; EVALUATION; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX RATIO;

BLOOD GLUCOSE; BLOOD PRESSURE; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCOSE CLAMP TECHNIQUE; HORMONES, ECTOPIC; HUMANS; HYPERTENSION; INSULIN; INSULIN RESISTANCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; RESISTIN; TRIGLYCERIDES;

EID: 0141504958     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2003.01879.x     Document Type: Article

References (22)

1. Agata, J., Miyazaki, Y., Takada, M., Murakami, H., Masuda, A., Miura, T., Ura, N. & Shimamoto, K. (1998) Association of insulin resistance and hyperinsulinemia with disturbed lipid metabolism in patients with essential hypertension. Hypertension Research, 21, 57-62.
2. DeFronzo, R.A. & Ferrannini, E. (1991) Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care, 14, 173-194.
3. DeFronzo, R.A., Tobin, J.D. & Andres, R. (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. American Journal of Physiology, 237, E214-E223.
4. Friedman, J.M. & Halaas, J.L. (1998) Leptin and the regulation of body weight in mammals. Nature, 395, 763-770.
5. Hotamisligil, G.S., Arner, P., Caro, J.F., Atkinson, R.L. & Spiegelman, B.M. (1995) Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. Journal of Clinical Investigation, 95, 2409-2415.
6. Hotamisligil, G.S., Shargill, N.S. & Spiegelman, B.M. (1993) Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science, 259, 87-91.
7. Iimura, O. (1996) Insulin resistance and hypertension in Japanese. Hypertension Research, 19, S1-S8.
8. Janke, J., Engeli, S., Gorzelniak, K., Luff, F.C. & Sharma, A.M. (2002) Resistin gene expression in human adipocytes is not related to insulin resistance. Obesity Research, 10, 1-5.
9. Kahn, B.B. & Flier, J.S. (2000) Obesity and insulin resistance. Journal of Clinical Investigation, 106, 473-481.
10. Kaplan, N.M. (1989) The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Archives of International Medicine, 149, 1514-1520.
11. Lind, L., Berne, C. & Lithell, H. (1995) Prevalence of insulin resistance in essential hypertension. Journal of Hypertension, 13, 1457-1462.
12. McTernan, P.G., McTernan, C.L., Chetty, R., Jenner, K., Fisher, F.M., Lauer, M.N., Crocker, J., Barnett, A.H. & Kumar, S. (2002) Increased resistin gene and protein expression in human abdominal adipose tissue. Journal of Clinical Endocrinology and Metabolism, 87, 2407-2410.
13. Montague, C.T., Prins, J.B., Sanders, L., Digby, J.E. & O'Rahilly, S. (1997) Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution. Diabetes, 46, 342-347.
14. Nagaev, I. & Smith, U. (2001) Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochemical and Biophysical Research Communications, 285, 561-564.
15. Reaven, G.M. (1988) Role of insulin resistance in human disease. Diabetes, 37, 1595-1607.
16. Roden, M., Price, T.B., Perseghin, G., Petersen, K.F., Rothman, D.L., Cline, G.W. & Shulman, G.I. (1996) Mechanism of free fatty acid-induced insulin resistance in humans. Journal of Clinical Investigation, 97, 2859-2865.
17. Savage, D.B., Sewter, C.P., Klenk, E.S., Segal, D.G., Vidal-Puig, A., Considine, R.V. & O'Rahilly, S. (2001) Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-γ action in humans. Diabetes, 50, 2199-2202.
18. Shimomura, I., Funahashi, T., Takahashi, M., Maeda, K., Kotani, K., Nakamura, T., Yamashita, S., Miura, M., Fukuda, Y., Takemura, K., Tokunaga, K. & Matsuzawa, Y. (1996) Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nature Medicine, 2, 800-803.
19. Shuldiner, A.R., Yang, R. & Gong, D.W. (2001) Resistin, obesity and insulin resistance - the emerging role of the adipocyte as an endocrine organ. New England Journal of Medicine, 345, 1345-1346.
20. Steppan, C.M. & Lazar, M.A. (2002) Resistin and obesity-associated insulin resistance. Trends of Endocrinology and Metabolism, 13, 18-23.
21. Steppan, C.M., Bailey, S.T., Bhat, S., Brown, E.J., Banerjee, R.R., Wright, C.M., Patel, H.R., Ahima, R.S. & Lazar, M.A. (2001) The hormone resistin links obesity to diabetes. Nature, 409, 307-312.
22. Way, J.M., Gorgun, C.Z., Tong, Q., Uysal, K.T., Brown, K.K., Harrington, W.W., Oliver, W.R. Jr, Willson, T.M., Kliewer, S.A. & Hotamisligil, G.S. (2001) Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor γ agonists. Journal of Biology Chemistry, 276, 25651-25653.